In utero exposure to thiopurines/anti-TNF agents and long-term health outcomes during childhood and adolescence in Denmark

Parental IBD and Long-term Health Outcomes in the Offspring

(2019) Bente Mertz Nørgård et al.   INFLAMMATORY BOWEL DISEASES

Obstetric Outcomes in Women with Rheumatoid Arthritis: Results from Nationwide Inpatient Sample Database 2003-2011

(2019) Shweta Kishore et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Mediation of Adverse Pregnancy Outcomes in Autoimmune Conditions by Pregnancy Complications

(2019) Gretchen Bandoli et al.   ARTHRITIS CARE & RESEARCH

Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)

(2018) Maxime Luu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

(2018) M Chaparro et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation

(2018) Dana Duricova et al.   INFLAMMATORY BOWEL DISEASES

Treating Ulcerative Colitis During Pregnancy: Evidence of Materno–Fetal Transfer of Golimumab

(2018) Laure Benoit et al.   Journal of Crohns & Colitis

The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease

(2017) Heidi Kammerlander et al.   INFLAMMATORY BOWEL DISEASES

Research challenges for drug-induced birth defects

(2016) AA Mitchell   CLINICAL PHARMACOLOGY & THERAPEUTICS

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

(2016) Mette Julsgaard et al.   GASTROENTEROLOGY

Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis

(2015) Aoibhlinn O’Toole et al.   DIGESTIVE DISEASES AND SCIENCES

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety

(2015) A de Lima et al.   GUT

Association between tumour necrosis factor-  inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

(2015) N. Nyboe Andersen et al.   BMJ-British Medical Journal

Association between tumour necrosis factor-  inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

(2015) N. Nyboe Andersen et al.   BMJ-British Medical Journal

The Danish National Patient Registry: a review of content, data quality, and research potential

(2015) Morten Schmidt et al.   Clinical Epidemiology

Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes

(2015) Heather A. Boyd et al.   PLoS One

Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease

(2013) T. G. J. de Meij et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease

(2013) Bindia Jharap et al.   GUT

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease

(2012) Mona Akbari et al.   INFLAMMATORY BOWEL DISEASES

The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy

(2012) J. R. Hutson et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY

In Utero Azathioprine Exposure and Increased Utilization of Special Educational Services in Children Born to Mothers With Systemic Lupus Erythematosus

(2012) Wendy Marder et al.   ARTHRITIS CARE & RESEARCH

Systemic inflammation disrupts the developmental program of white matter

(2011) Géraldine Favrais et al.   ANNALS OF NEUROLOGY

The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)

(2011) Lisa Shim et al.   Journal of Crohns & Colitis

Elevated Concentrations of Inflammation-Related Proteins in Postnatal Blood Predict Severe Developmental Delay at 2 Years of Age in Extremely Preterm Infants

(2011) T. Michael O’Shea et al.   JOURNAL OF PEDIATRICS

Schizophrenia and Autism: Both Shared and Disorder-Specific Pathogenesis Via Perinatal Inflammation?

(2011) URS MEYER et al.   PEDIATRIC RESEARCH

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study

(2010) J. Coelho et al.   GUT

European evidenced-based consensus on reproduction in inflammatory bowel disease

(2010) C. Janneke van der Woude et al.   Journal of Crohns & Colitis

Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding

(2010) Sieglinde Angelberger et al.   Journal of Crohns & Colitis

Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding

(2010) B. G. Berthelsen et al.   RHEUMATOLOGY

A Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia

(2008) U. Meyer et al.   SCHIZOPHRENIA BULLETIN